Steward Partners Investment Advisory, LLC Vyne Therapeutics Inc. Transaction History

Steward Partners Investment Advisory, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 15, 2023	SELL	$0.12 - $4.91 $54 - $2,209	-450 Reduced 41.67%	630 $0
Q1 2022 May 02, 2022	SELL	$0.5 - $1.15 $450 - $1,035	-900 Reduced 45.45%	1,080 $1,000
Q4 2021 Feb 08, 2022	SELL	$0.91 - $1.5 $1,638 - $2,700	-1,800 Reduced 47.62%	1,980 $2,000
Q2 2021 Aug 13, 2021	SELL	$3.24 - $6.92 $10,614 - $22,669	-3,276 Reduced 46.43%	3,780 $13,000
Q1 2021 May 14, 2021	BUY	$6.34 - $12.68 $44,735 - $89,470	7,056 New	7,056 $48,000

36.5K

Ticker VYNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,005,600
Market Cap $176M
Description
VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, whi...

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.